Home Cart Sign in  
Chemical Structure| 176969-34-9 Chemical Structure| 176969-34-9

Structure of 176969-34-9

Chemical Structure| 176969-34-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 176969-34-9 ]

CAS No. :176969-34-9
Formula : C6H6F2N2O2
M.W : 176.12
SMILES Code : O=C(C1=CN(C)N=C1C(F)F)O
MDL No. :MFCD11865267
InChI Key :RLOHOBNEYHBZID-UHFFFAOYSA-N
Pubchem ID :18983008

Safety of [ 176969-34-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Computational Chemistry of [ 176969-34-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 12
Num. arom. heavy atoms 5
Fraction Csp3 0.33
Num. rotatable bonds 2
Num. H-bond acceptors 5.0
Num. H-bond donors 1.0
Molar Refractivity 35.52
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

55.12 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.99
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.41
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

1.57
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

0.6
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.63
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.84

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.37
Solubility 7.57 mg/ml ; 0.043 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.13
Solubility 12.9 mg/ml ; 0.0734 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.78
Solubility 29.6 mg/ml ; 0.168 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-7.08 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.63

Application In Synthesis of [ 176969-34-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 176969-34-9 ]

[ 176969-34-9 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 1001-26-9 ]
  • [ 1550-50-1 ]
  • [ 60-34-4 ]
  • [ 176969-34-9 ]
YieldReaction ConditionsOperation in experiment
50% To a solution of 1,1,2,2-tetrafluoroethyldimethylamine (3.2 g, 22 mmol) in diethyl ether (10 ml) and dioxane (10 ml) was added dropwise, under a nitrogen atmosphere, at a temperature of from 0 to 5° C., a solution of BF3-etherate (49percent BF3, 5.6 ml, 44 mmol). After the addition had ended, the reaction mixture was stirred for 5 min. Subsequently, pyridine (1.7 g, 22 mmol) and a solution of <strong>[1001-26-9]ethyl 3-ethoxyacrylate</strong> (2.9 g, 20 mmol) in dioxane (2 ml) were added dropwise successively to the reaction mixture at a temperature of from 0 to 5° C. After stirring at room temperature for 6 hours, the reaction mixture was added at a temperature of from 0 to 5° C. to a mixture of sodium hydroxide (4.4 g, 110 mmol) and methylhydrazine (1.4 g, 30 mmol) in water (75 ml) and then stirred at room temperature for 1 h. Subsequently, the reaction mixture was heated to 60° C. and stirred at this temperature for 0.5 h. The reaction mixture was freed of volatile constituents. The resulting residue was taken up in water (50 ml), washed with ethyl acetate and then brought to a pH of 2 with conc. hydrochloric acid. The precipitated solid was isolated by filtration, washed with water and dried under reduced pressure at a temperature of 50° C. Isomerically pure 3-difluoromethyl-1-methylpyrazole-4-carboxylic acid was obtained in a yield of 50percent.
  • 2
  • [ 1550-50-1 ]
  • [ 34846-90-7 ]
  • [ 60-34-4 ]
  • [ 176969-34-9 ]
  • [ 1204298-65-6 ]
YieldReaction ConditionsOperation in experiment
To a solution of 1,1,2,2-tetrafluoroethyldimethylamine (30 g, 207 mmol) in diethyl ether (90 ml) and dioxane (90 ml) was added dropwise, under a nitrogen atmosphere, at a temperature of from 0 to 5° C., a solution of BF3-etherate (49percent BF3, 59.6 ml, 420 mmol). After the addition had ended, the reaction mixture was stirred for 5 min. Subsequently, pyridine (15.9 g, 201 mmol) and methyl 3-methoxyacrylate (22.3 g, 186 mmol) were successively added dropwise to the reaction mixture at a temperature of from 0 to 5° C. After stirring for 6 hours, a greasy solid formed, from which the supernatant solution was decanted off and discarded. The solid was then added at a temperature of from 0 to 5° C. to a mixture of sodium hydroxide (41.4 g, 1.035 mol) and methylhydrazine (38.6 g of a 35percent aqueous solution, 288 mmol) in water (665 ml) and then stirred at room temperature for 1 h. Subsequently, the reaction mixture was heated to 60° C. and stirred at this temperature for 0.5 h. The reaction mixture was freed of volatile constituents. The resulting residue was taken up in water (50 ml), washed with ethyl acetate and then brought to a pH of 2 with conc. hydrochloric acid. The solid precipitated at a temperature of 0° C. was isolated by filtration, washed with a little ice-cold water and dried under reduced pressure at a temperature of 40° C. 3-Difluoro-methyl-1-methylpyrazole-4-carboxylic acid was obtained as a mixture with 5-difluoro-methyl-1-methylpyrazole-4-carboxylic acid with a ratio of 85:15 in an amount of 10.1 g.
  • 3
  • [ 176969-34-9 ]
  • [ 22312-62-5 ]
  • C20H18F2N4O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
80.4% With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20℃; for 6h; General procedure: Intermediate d (10 mmol), EDCI (10 mmol), DMAP (0.1 mmol), and aromatic acid (10 mmol)were dissolved in DCM (CH2Cl2, 30 mL). The mixture was stirred at room temperature for 6 h.The target compounds 1-10 were purified via column chromatography. Similarly, the intermediateb, e, f, and target compounds 11-20 were synthesized by using the same methods. The spectrogram oftarget compounds 1-20 are presented as Supporting Information.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 176969-34-9 ]

Fluorinated Building Blocks

Chemical Structure| 113100-53-1

A112969 [113100-53-1]

1-Methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

Similarity: 0.97

Chemical Structure| 141573-95-7

A197104 [141573-95-7]

Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate

Similarity: 0.92

Chemical Structure| 61859-96-9

A238366 [61859-96-9]

Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate

Similarity: 0.86

Chemical Structure| 155377-19-8

A108874 [155377-19-8]

Ethyl 3-(trifluoromethyl)pyrazole-4-carboxylate

Similarity: 0.84

Chemical Structure| 1202993-11-0

A170478 [1202993-11-0]

5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.82

Carboxylic Acids

Chemical Structure| 113100-53-1

A112969 [113100-53-1]

1-Methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

Similarity: 0.97

Chemical Structure| 78703-53-4

A140054 [78703-53-4]

1,3-Dimethyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.83

Chemical Structure| 1202993-11-0

A170478 [1202993-11-0]

5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.82

Chemical Structure| 40704-11-8

A763073 [40704-11-8]

3-Methyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.76

Chemical Structure| 5952-92-1

A239339 [5952-92-1]

1-Methyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.72

Difluoromethyls

Chemical Structure| 141573-95-7

A197104 [141573-95-7]

Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate

Similarity: 0.92

Chemical Structure| 1202993-11-0

A170478 [1202993-11-0]

5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.82

Chemical Structure| 660845-30-7

A124308 [660845-30-7]

5-Chloro-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carbaldehyde

Similarity: 0.70

Chemical Structure| 1204298-65-6

A292176 [1204298-65-6]

5-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.62

Chemical Structure| 1089212-38-3

A171677 [1089212-38-3]

4-Bromo-3-(difluoromethyl)-1-methyl-1H-pyrazole

Similarity: 0.57

Related Parent Nucleus of
[ 176969-34-9 ]

Pyrazoles

Chemical Structure| 113100-53-1

A112969 [113100-53-1]

1-Methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

Similarity: 0.97

Chemical Structure| 141573-95-7

A197104 [141573-95-7]

Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate

Similarity: 0.92

Chemical Structure| 61859-96-9

A238366 [61859-96-9]

Methyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate

Similarity: 0.86

Chemical Structure| 155377-19-8

A108874 [155377-19-8]

Ethyl 3-(trifluoromethyl)pyrazole-4-carboxylate

Similarity: 0.84

Chemical Structure| 78703-53-4

A140054 [78703-53-4]

1,3-Dimethyl-1H-pyrazole-4-carboxylic acid

Similarity: 0.83